Related Experiment Video

Updated: May 27, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Pathogenesis and pathophysiology of aortic valve stenosis in adults

Maria Olszowska1

  • 1Department of Social Cardiology, Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University, Medical College, Kraków, Poland.

Polskie Archiwum Medycyny Wewnetrznej
|December 2, 2011
PubMed

Insights

Degenerative aortic stenosis (AS), the most common valvular heart disease, involves lipid accumulation, inflammation, and calcification. Understanding these processes aids in early prevention and therapy.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Pathology

Background:

  • Aortic stenosis (AS) is the most prevalent valvular heart disease, predominantly of degenerative origin.
  • AS is characterized by persistent lipid accumulation, inflammation, and calcification.
  • Valve calcification is an active process resembling bone formation, involving matrix remodeling and angiogenesis.

Purpose of the Study:

  • To elucidate the key pathological processes in degenerative aortic stenosis.
  • To highlight the similarities between AS and atherosclerosis pathogenesis.
  • To emphasize the importance of early-stage understanding for prevention and therapy.

Main Methods:

  • Review of recent studies on aortic stenosis pathogenesis.
  • Analysis of cellular and molecular mechanisms in valve calcification.
  • Comparison of risk factors and pathways in AS and atherosclerosis.

Main Results:

  • Degenerative AS involves active, regulated processes including inflammation and calcification.
  • Valve calcification shares mechanisms with atherosclerosis, such as lipid accumulation and inflammation.
  • Early-stage understanding of AS pathogenesis is crucial for effective interventions.

Conclusions:

  • Degenerative aortic stenosis is a complex, active disease process.
  • Shared pathways with atherosclerosis offer therapeutic targets.
  • Further research into these mechanisms can improve patient outcomes.

More Related Videos

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...